OPRM1 and opioid use disorder: As discussed above, the G-protein biased MOR partial agonist activity may be part of the reason for dezocine’s lower propensity to induce dependence, but other MOR partial agonists and other G-protein biased MOR agonists currently used to treat opioid use disorder still possess a risk of addiction.